Role of IL-15 in immune-mediated and infectious diseases (Q28298240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074481

26 August 2024

5

Gino R. Corazza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074481

26 August 2024

author name string

Francesca Vidali

3

0 references

Sandra A. Calarota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074481

26 August 2024

Thomas T. Macdonald

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074481

26 August 2024

language of work or name

English

0 references

publication date

February 2011

0 references

11 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074481

full work available at URL

26 August 2024

https://api.elsevier.com/content/article/PII:S1359610110000663?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

https://api.elsevier.com/content/article/PII:S1359610110000663?httpAccept=text/plain

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Cytokine and Growth Factor Reviews

26 August 2024

published in

0 references

volume

22

0 references

issue

1

0 references

page(s)

19-33

0 references

cites work

IL-15/IL-15 receptor biology: a guided tour through an expanding universe

1

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Structural biology of shared cytokine receptors

26 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.

26 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Trans-presentation: a novel mechanism regulating IL-15 delivery and responses

26 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

26 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

26 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation

26 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation.

26 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 15: biology and relevance to human disease

26 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Survival adjustment of mature dendritic cells by IL-15.

26 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 and its impact on neutrophil function

26 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation

26 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression

26 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

26 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

26 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

26 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain

26 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression

26 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs.

26 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Generation and maintenance of memory CD4(+) T Cells

26 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Regulation of memory T cells by γc cytokines

26 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells

26 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

26 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory

26 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation

26 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets

26 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

New insights into the regulation of T cells by gamma(c) family cytokines

26 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.

26 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Phenotypic and functional features of human Th17 cells

26 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro.

26 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 expression affects homeostasis and function of B cells through NK cell-derived interferon-gamma.

26 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

26 August 2024

Coeliac disease

32

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.

26 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD).

26 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease

26 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

26 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease

26 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

26 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation

26 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 15 mediates epithelial changes in celiac disease

26 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Inhibition of TGF-β Signaling by IL-15: A New Role for IL-15 in the Loss of Immune Homeostasis in Celiac Disease

26 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

26 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 15: its role in intestinal inflammation.

26 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

26 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease

26 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease

26 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease

26 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes

26 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Inflammatory bowel disease: clinical aspects and established and evolving therapies

26 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Immunity, inflammation, and allergy in the gut.

26 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation

26 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice

26 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production

26 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease.

26 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions

26 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD

26 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease

26 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Immunology of multiple sclerosis

26 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice

26 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis

26 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis

26 August 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis

26 August 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.

26 August 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Mechanisms of skin fibrosis in systemic sclerosis

26 August 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Animal model of systemic sclerosis

26 August 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma

26 August 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease

26 August 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis

26 August 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Immunologic rheumatic disorders

26 August 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Cytokines in the pathogenesis of rheumatoid arthritis

26 August 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-7 and IL-15: biology and roles in T-Cell immunity in health and disease

26 August 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 selectively expands CD57+ CD28- CD4+ T cells, which are increased in active rheumatoid arthritis

26 August 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production

26 August 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

26 August 2024

Psoriasis

74

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?

26 August 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis

26 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 and psoriasis: another genetic link to Th17?

26 August 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association

26 August 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

26 August 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection

26 August 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses

26 August 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques.

26 August 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects

26 August 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques

26 August 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment

26 August 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates

26 August 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Role of natural killer cells in HIV pathogenesis

26 August 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients

26 August 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Circulating levels of IL-7 but not IL-15, IGF-1, and TGF-beta are elevated during primary HIV-1 infection

26 August 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

26 August 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression

26 August 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection.

26 August 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Studies on the production of IL-15 in HIV-infected/AIDS patients.

26 August 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

26 August 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.

26 August 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission

26 August 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans.

26 August 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease

26 August 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 and HIV infection: lessons for immunotherapy and vaccination

26 August 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Disruption of the gamma c cytokine network in T cells during HIV infection

26 August 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis?

26 August 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease

26 August 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15

26 August 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection

26 August 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2

26 August 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

A regulatory role of interleukin 15 in wound healing and mucosal infection in mice.

26 August 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Immunology of hepatitis B virus and hepatitis C virus infection

26 August 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

The immune response during hepatitis B virus infection

26 August 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

26 August 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

26 August 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection

26 August 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection

26 August 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 regulates CD8+ T cell contraction during primary infection.

26 August 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.

26 August 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool

26 August 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Impaired protection against Mycobacterium bovis bacillus Calmette-Guerin infection in IL-15-deficient mice.

26 August 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 protects antigen-specific CD8+ T cell contraction after Mycobacterium bovis bacillus Calmette-Guérin infection

26 August 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues

26 August 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis

26 August 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities.

26 August 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

26 August 2024

The curiosity of IL-15

121

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

CD8+ T cells in Trypanosoma cruzi infection

26 August 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection

26 August 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy.

26 August 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii

26 August 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite

26 August 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

26 August 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

26 August 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

26 August 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

26 August 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Selectivity and therapeutic inhibition of kinases: to be or not to be?

26 August 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders

26 August 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.

26 August 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

26 August 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

26 August 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

The relevance of cytokines for development of protective immunity and rational design of vaccines

26 August 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies

26 August 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

26 August 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

26 August 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

26 August 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques

26 August 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge

26 August 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251.

26 August 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit

26 August 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.CYTOGFR.2010.09.003

26 August 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017